Mutual Drug Revenue and Competitors
Estimated Revenue & Valuation
- Mutual Drug's estimated annual revenue is currently $7.5M per year.
- Mutual Drug's estimated revenue per employee is $163,043
Employee Data
- Mutual Drug has 46 Employees.
- Mutual Drug grew their employee count by 7% last year.
Mutual Drug Competitors & Alternatives
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $15M | 169 | 17% | N/A | N/A |
#2 | $7.5M | 48 | 14% | N/A | N/A |
#3 | $75M | 54 | 26% | N/A | N/A |
#4 | $35M | 62 | 0% | N/A | N/A |
#5 | $15M | 148 | 25% | N/A | N/A |
#6 | $35M | 44 | 16% | N/A | N/A |
#7 | $35M | 40 | 18% | N/A | N/A |
#8 | N/A | 73 | 20% | N/A | N/A |
#9 | $75M | 34 | -6% | N/A | N/A |
#10 | $7.5M | 77 | 93% | N/A | N/A |
What Is Mutual Drug?
Mutual Drug helps ensure that its members are successful through a collaboration of over 500 pharmacies, strong group buying power, transparent pricing, improved access to products and services, legislative advocacy, and a full suite of business support solutions. Mutual Drug is shaping a better future for independent pharmacies through technology and a focused approach to product distribution.
keywords:N/A
N/A
Total Funding
46
Number of Employees
$7.5M
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Mutual Drug News
... Alliance Provides Mutual Customer Benefits for Pharmaceutical and ... accuracy in the proofreading process for drug labels and related...
... mutual recognition agreement (MRA) in the pharmaceutical segment could ... to manufacture and supply a key critical care drug to Japan.
Smith Drug; FFF Enterprises; Patterson; Mutual Drug; Shanghai Pharmaceutical; Medline. To Understand How Covid-19 Impact Is Covered in This...
Other Companies in Durham
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5.7M | 46 | 24% | N/A |
#2 | $9.2M | 46 | -2% | N/A |
#3 | $6.6M | 46 | 2% | N/A |
#4 | $5.3M | 46 | N/A | N/A |
#5 | $10.3M | 46 | 18% | N/A |
